Literature DB >> 30843035

Likelihood of Smoking Among Cancer Survivors: An Updated Health Information National Trends Survey Analysis.

Christine M Swoboda1, Daniel M Walker1, Timothy R Huerta1,2.   

Abstract

INTRODUCTION: Cancer survivors are at high risk for cancer reoccurrence, highlighting the importance of managing behavioral risk factors for cancer. Despite this risk, many cancer survivors continue to smoke cigarettes. This article describes the relationship between smoking behavior and demographic and clinical factors in cancer survivors.
METHODS: Multinomial logistic regression of cross-sectional data from the Health Information National Trends Survey was conducted using combined data from years 2003, 2005, 2007, 2011, 2012, 2013, and 2014. Independent variables included age, cancer history, race, education level, marital status, insurance status, and data year; the dependent variable was smoking status (current vs. former or never).
RESULTS: Cancer survivors were less likely to be current smokers but more likely to be former smokers than those with no history of cancer. Cancer survivors that currently smoked were more likely to have lower education levels, be divorced, separated, or single, or not have health insurance. Older cancer survivors, Hispanic, and non-Hispanic black survivors were less likely to smoke. Among cancer subgroups, prostate cancer survivors had the lowest rate (8.8%) of current smoking from 2011 to 2014, and cervical cancer survivors had the highest rate (31.1%).
CONCLUSIONS: Although those with no history of cancer had higher rates of current smoking, many subgroups of cancer survivors continued to smoke at higher rates than average cancer survivors. Cancer survivors that were younger, had lower education levels, were any marital status other than married or widowed, were uninsured, or survived cervical cancer were more likely to be smokers than other survivors. IMPLICATIONS: It is important to understand which types of cancer survivors are at high risk of continued smoking to better inform tobacco dependence treatment interventions among those at high risk of cancer reoccurrence. Our findings suggest targeted tobacco dependence treatment efforts among cancer survivors should focus on survivors of cervical cancer and survivors that are young, unmarried, uninsured, or have lower education levels.
© The Author(s) 2019. Published by Oxford University Press on behalf of the Society for Research on Nicotine and Tobacco. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Mesh:

Year:  2019        PMID: 30843035     DOI: 10.1093/ntr/ntz007

Source DB:  PubMed          Journal:  Nicotine Tob Res        ISSN: 1462-2203            Impact factor:   4.244


  10 in total

1.  Associations of Daily Versus Nondaily Smoking, Tobacco-Related Risk Perception, and Cancer Diagnosis Among Adults in the Population Assessment of Tobacco and Health (PATH) Study.

Authors:  Stephanie R Land; Laura Baker; Jacqueline Bachand; Jenny Twesten; Annette R Kaufman; Carolyn M Reyes-Guzman
Journal:  Nicotine Tob Res       Date:  2022-10-17       Impact factor: 5.825

2.  A descriptive study of cervical cancer survivors' persistent smoking behavior and perceived barriers to quitting.

Authors:  Tia N Borger; Gabriella E Puleo; Jessica N Rivera Rivera; Devin Montgomery; William R Bowling; Jessica L Burris
Journal:  Psychol Addict Behav       Date:  2021-03-25

3.  Prevalence and Predictors of Sustained Smoking after a Cancer Diagnosis in Korean Men.

Authors:  Hye Yeon Koo; Kiheon Lee; Sang Min Park; Jooyoung Chang; Kyuwoong Kim; Seulggie Choi; Mi Hee Cho; Jihye Jun; Sung Min Kim
Journal:  Cancer Res Treat       Date:  2019-06-25       Impact factor: 4.679

4.  Continued smoking in African American cancer survivors: The Detroit Research on Cancer Survivors Cohort.

Authors:  Carly M Malburg; Juliana Fucinari; Julie J Ruterbusch; David M Ledgerwood; Jennifer L Beebe-Dimmer; Ann G Schwartz; Michele L Cote
Journal:  Cancer Med       Date:  2020-08-21       Impact factor: 4.452

5.  Evaluation of the Efficacy of a Smoking Cessation Intervention for Cervical Cancer Survivors and Women With High-Grade Cervical Dysplasia: Protocol for a Randomized Controlled Trial.

Authors:  Sarah R Jones; Damon J Vidrine; David W Wetter; Ya-Chen Tina Shih; Steven K Sutton; Lois M Ramondetta; Linda S Elting; Joan L Walker; Katie M Smith; Summer G Frank-Pearce; Yisheng Li; Vani N Simmons; Jennifer I Vidrine
Journal:  JMIR Res Protoc       Date:  2021-12-30

6.  Has the National Fall in Smoking Rates in Ireland Been Replicated in Cancer Patients? A 5-Year Report.

Authors:  Patricia Fitzpatrick; Nancy Bhardwaj; Ailsa Lyons; Kirsten Doherty; Kate Frazer; Amanda McCann; Vikram Niranjan; Shiraz Syed; Patricia Fox
Journal:  Int J Environ Res Public Health       Date:  2022-02-18       Impact factor: 3.390

7.  Affordable Care Act Medicaid expansion and access to primary-care based smoking cessation assistance among cancer survivors: an observational cohort study.

Authors:  Steffani R Bailey; Robert Voss; Heather Angier; Nathalie Huguet; Miguel Marino; Steele H Valenzuela; Katherine Chung-Bridges; Jennifer E DeVoe
Journal:  BMC Health Serv Res       Date:  2022-04-12       Impact factor: 2.655

8.  The impact of hyperbaric oxygen therapy on late irradiation injury in oral microcirculation.

Authors:  Renée Helmers; Dan M J Milstein; Nina F Straat; Arash Navran; David N Teguh; Robert A van Hulst; Ludi E Smeele; Jan de Lange
Journal:  Head Neck       Date:  2022-04-29       Impact factor: 3.821

9.  Tobacco Use and Tobacco Treatment Referral Response of Patients With Cancer: Implementation Outcomes at a National Cancer Institute-Designated Cancer Center.

Authors:  Jessica L Burris; Tia N Borger; Brent J Shelton; Audrey K Darville; Jamie L Studts; Joseph Valentino; Courtney Blair; D Bront Davis; Joan Scales
Journal:  JCO Oncol Pract       Date:  2021-06-29

10.  Patient-Level Factors Associated with Oncology Provider-Delivered Brief Tobacco Treatment Among Recently Diagnosed Cancer Patients.

Authors:  J M Neil; S N Price; E R Friedman; C Ponzani; J S Ostroff; A Muzikansky; E R Park
Journal:  Tob Use Insights       Date:  2020-08-17
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.